VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 715 filers reported holding VANECK VECTORS ETF TR in Q4 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $310,778 | -10.6% | 11,549 | 0.0% | 0.08% | -7.1% |
| Q2 2023 | $347,734 | -6.9% | 11,549 | 0.0% | 0.08% | -10.6% |
| Q1 2023 | $373,603 | +12.9% | 11,549 | 0.0% | 0.09% | +10.6% |
| Q4 2022 | $330,987 | +20.8% | 11,549 | +1.6% | 0.08% | +10.4% |
| Q3 2022 | $274,000 | -11.9% | 11,363 | 0.0% | 0.08% | -7.2% |
| Q2 2022 | $311,000 | -28.7% | 11,363 | 0.0% | 0.08% | -17.8% |
| Q1 2022 | $436,000 | -20.0% | 11,363 | -33.3% | 0.10% | -23.5% |
| Q4 2021 | $545,000 | +10.5% | 17,025 | +1.7% | 0.13% | -3.6% |
| Q3 2021 | $493,000 | -13.4% | 16,734 | 0.0% | 0.14% | -14.9% |
| Q2 2021 | $569,000 | +56.7% | 16,734 | +49.8% | 0.16% | +33.1% |
| Q1 2021 | $363,000 | -9.7% | 11,169 | 0.0% | 0.12% | -17.7% |
| Q4 2020 | $402,000 | – | 11,169 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |